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Nitric oxide (NO) plays an important role in the protec-
tion against the onset and progression of various cardio-
vascular diseases, including hypertension and
atherosclerosis, which are associated with an apparently
reduced NO bioavailability. Therefore, the NO/cGMP sig-
naling pathway has gained considerable attention and has
become a target for new drug development. We have
established a rapid, homogeneous, cell-based and highly
sensitive nitric oxide reporter assay which is suitable for
ultra-high-throughput screening. In our coculture system,
endothelial nitric oxide synthase (eNOS) mediated NO
generation is monitored in living cells via soluble guany-
lyl cyclase (sGC) activation and calcium influx through
the olfactory cyclic nucleotide-gated (CNG) cation chan-
nel CNGA2, acting as the intracellular cGMP sensor [1].
Using this NO reporter assay, a fully automated high-
throughput screening campaign for stimulators of NO
synthesis was performed. The coculture system reflects
most aspects of the natural NO/cGMP signaling pathway.
Namely, Ca2+-dependent and Ca2+-independent regula-
tion of eNOS activity by G protein-coupled receptor ago-
nists, oxidative stress, phosphorylation, and cofactor
availability, as well as NO-mediated stimulation of cGMP
synthesis by sGC activation. The reporter assay allows the
real-time detection of NO synthesis within living cells and
makes it possible to identify and characterize activators
and inhibitors of enzymes involved in the NO/cGMP
pathway.
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